USPTO serial 79283880
VICORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 6, 2021
- Examiner
- PODESTA, GIDETTE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VICORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah J. Schneider
Sarah J. Schneider Sheridan Ross P.C.1560 Broadway, Suite 1200Denver, CO 80202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills, tablets, capsules, caplets, and liquid drops sachets for the treatment fibrotic lung disease | ACTIVE | — |
| 042 | Medical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosis, namely, ipf, pulmonary sarcoidosis and diffuse systemic sclerosis, in particular in the field of lung manifestations; pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; pharmaceutical drug delivery system development services; pharmaceutical drug development services, namely, preparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto in the nature of professional expertise in the field of clinical research for others; all of the foregoing services for the treatment of fibrotic lung disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 22, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 21, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 23, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 1, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 6, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 6, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 31, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 16, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 24, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 19, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 19, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 30, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 30, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 30, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 14, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 29, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 29, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 29, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 14, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 14, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 1, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 24, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |